NIH Guide for Grants and Contracts
October 09, 2020
Weekly NIH Funding Opportunities and Notices
Policy Notices
- NIAMS Policy for Acceptance of Clinical Trial Applications and Participation in Parent R01 and R21(Clinical Trial Required) Announcements
(NOT-AR-21-009)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
General Notices
- Pre-Application Webinar for RFA-CA-20-053, Genomic Data Analysis Network: Genomic Data Analysis Center (U24 Clinical Trial Not Allowed)
(NOT-CA-21-002)
National Cancer Institute
- Notice of Technical Assistance Webinar and Frequently Asked Questions (FAQs) for NHLBI HeartShare RFA-HL-21-015 "Clinical Centers (U01)" and RFA-HL-21-016 "Data Translation Center (U54)"
(NOT-HL-20-819)
National Heart, Lung, and Blood Institute
- Consolidated Notice on NIMH Clinical Trials Policies
(NOT-MH-20-105)
National Institute of Mental Health
- Notice of Clarification to the High-Risk, High-Reward Research Program: Pioneer: RFA-RM-20-011, New Innovator: RFA-RM-20-012, Transformative Research (RFA-RM-20-013, RFA-RM-20-020 & NOT-RM-20-019), and Early Independence (RFA-RM-20-014 & RFA-RM-20-021)
(NOT-RM-21-004)
Office of Strategic Coordination (Common Fund)
- Request for Information on Processes for NRGR Sample Submission, Access, and Management
(NOT-MH-21-010)
National Institute of Mental Health
- Request for Information: Data Science Challenges and Opportunities in the Field of Precision Nutrition
(NOT-RM-21-005)
Office of Strategic Coordination (Common Fund)
Notice of Changes to Funding Opportunities
- Notice of Extension of the Expiration Date of PAR-19-363 "Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)"
(NOT-CA-21-001)
National Cancer Institute
- Notice of Correction to RFA-CA-20-047 Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)"
(NOT-CA-21-004)
National Cancer Institute
- Notice of Correction to RFA-CA-20-052 Limited Competition: Childhood Cancer Survivor Study (U24 Clinical Trial Required)
(NOT-CA-21-005)
National Cancer Institute
- Notice to Extend the Expiration Date for PAR-18-433 "NIBIB Exploratory/Developmental Research Grant Program (R21 Clinical Trial Optional)"
(NOT-EB-20-013)
National Institute of Biomedical Imaging and Bioengineering
- Notice of Change to Receipt Date for RFA-HG-20-014, RFA-HG-20-015, and RFA-HG-20-016: NHGRI Synthetic Nucleic Acid Technology Development FOAs
(NOT-HG-21-005)
National Human Genome Research Institute
- Notice of Change: Correction of Calendar Months Expected To Be Devoted on RFA-HG-20-044 and RFA-HG-20-047 which are part of the "Impact of Genomic Variation on Function Consortium"
(NOT-HG-21-012)
National Human Genome Research Institute
- Notice of Extension to PA-18-350, "NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed)"
(NOT-MH-21-040)
National Institute of Mental Health
- Notice of Early Termination of PAR-18-909, Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trial Not Allowed)
(NOT-TR-21-003)
National Center for Advancing Translational Sciences
- Notice of Early Termination of PAR-18-910, Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01 Clinical Trial Required)
(NOT-TR-21-004)
National Center for Advancing Translational Sciences
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Aging Effects on Osteoimmunology (Clinical Trials Not Allowed)
(NOT-AG-20-051)
National Institute on Aging
Funding Opportunities
-
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
(PA-20-275)
National Institutes of Health
John E. Fogarty International Center
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of Research on Women's Health
Application Receipt Date(s): A successor-in-interest request must be made before the anticipated start date at the new organization and preferably several months in advance.
-
National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional)
(PAR-20-306)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): New applications: November 19, 2020, February 9, 2021, June 9, 2021, and October 8 2021; February 9, 2022, June 9, 2022, and October 7 2022; February 9 2023, June 9, 2023, by 5:00 PM local time of applicant organization. Resubmission and revision applications: November 19, 2020, March 9, 2021, July 9, 2021, and November 9 2021; March 9, 2022, July 8, 2022, November 9 2022; March 9 2023, July 7, 2023, by 5:00 PM local time of applicant organization.
-
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
(PAR-20-307)
National Institute of Mental Health
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) below.
-
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
(PAR-20-308)
National Institute of Mental Health
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s)
-
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
(PAR-21-030)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): Standard datesapply The first standard due date for this FOA is January 5, 2021.
-
MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed)
(RFA-AG-21-027)
National Institute on Aging
Application Receipt Date(s): February 3, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Coccidioidomycosis Collaborative Research Centers (U19 Clinical Trial Not Allowed)
(RFA-AI-20-056)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): February 18, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed)
(RFA-AI-20-064)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): February 8, 2021